bullish
Genor (嘉和生物) Pre-IPO: Slow R&D Progress in the past but that Might Change
413 Views19 Jul 2020 13:54
Gencor Biopharmaceutical (hereafter Gencor) is a China based biotech company with a focus on oncology and autoimmune drugs with development...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 11-minute read)
Discussions
(Paid Plans Only)
x